Center for FDA Rejuvenation

Center for FDA Rejuvenation (Registered Trademark)

Under Development

This Center will focus on decreasing the time to license anti-cancer drugs.

Suggestions from the public welcome.

The  Center will be  managed by the Center for Regulatory Effectiveness (CRE), a regulatory watchdog founded and managed by former regulatory officials  of the White House Office of Management and Budget.

CRE manages a number of websites dedicated to rejuvenating the federal regulatory decision-making  including   increasing the transparency of the regulatory process, see  TheOMB.US, a website focused on OMB’s role in centralized regulatory review beginning with the Johnson Administration and updated constantly to reflect the actions of the current Administration .

CRE also manages  OIRA Watch, a website dedicated to an analysis of the actions of the  Office of Information and Regulatory Affairs in the White House Office of Management and Budget, the cockpit of the regulatory state  which was  founded  in large part  by CRE officials during their federal service.

CRE personnel through years of government service have made notable contributions  to streamlining the federal regulatory process by using  tools designed  for regulating the regulators”.

To this end CRE will develop a  Forum which is an Interactive Public Docket (IPD) which allows the public and stakeholders to communicate  each other and to CRE on the best ways to breathe fresh thoughts into the FDA  drug licensing process for anti-cancer treatments. The format of the IPD for the Center for FDA Rejuvenation will be similar to that used for OIRA Watch and will have a website dedicated solely to its activities and therefore will not be on this website.


Leave a Reply

nine − six =